Erratum: Protective Effect of Apocynin in a Mouse Model of Chemically-Induced Colitis (Planta Medica (2013) 79:15 (1392-1400) DOI: 10.1055/s-0033-1350710);Protective effect of apocynin in a mouse model of chemically-induced colitis

Planta Medica

Volumn 79, Issue 15, 2013, Pages 1392-1400

  Marín, Marta ^a   Giner, Rosa María ^a   Ríos, José Luis ^a   Recio, María Del Carmen ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

apocynin; dextran sulfate sodium; inflammatory bowel disease; inflammatory cytokines; Picrorhiza kurroa; Scrophulariaceae; ulcerative colitis

Indexed keywords

APOCYNIN; CYCLOOXYGENASE 2; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; NITRIC OXIDE; NITRITE; PROSTAGLANDIN E2; RUTOSIDE; SALAZOSULFAPYRIDINE; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE ACTIVITY; ENZYME ACTIVITY; FECES ANALYSIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RECTUM HEMORRHAGE; ULCERATIVE COLITIS; UPREGULATION; WEIGHT REDUCTION;

MUS; PICRORHIZA KURROOA; SCROPHULARIACEAE;

ACETOPHENONES; ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; COLON; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DEXTRAN SULFATE; DINOPROSTONE; DISEASE MODELS, ANIMAL; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PICRORHIZA; PLANT EXTRACTS; RUTIN; STAT3 TRANSCRIPTION FACTOR; SULFASALAZINE; TRANSCRIPTION FACTOR RELA;

EID: 84886102293     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1350889     Document Type: Erratum

References (44)

1. Kaser A., Zeissig S., Blumberg R. S. Inflammatory bowel disease. Annu Rev Immunol: 2010; 28 573 621
2. Krieglstein C. F., Cerwinka W. H., Laroux F. S., Salter J. W., Russell J. M., Schuermann G., Grisham M. B., Ross C. R., Granger D. N. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen, divergent roles of superoxide and nitric oxide. J Exp Med: 2001; 194 1207 1218 (Pubitemid 33055040)
3. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P. A., Scholmerich J., Gross V. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology: 1998; 115 357 369 (Pubitemid 28363428)
4. Pallone F., Monteleone G. Mechanisms of tissue damage in inflammatory bowel disease. Curr Opin Gastroenterol: 2001; 17 307 312 (Pubitemid 32619970)
5. Perše M., Cerar A. Dextran sodium sulphate colitis mouse model, traps and tricks. J Biomed Biotechnol advance online publication 4 May 2012 10.1155/2012/718617
6. Sánchez-Fidalgo S., Cárdeno A., Villegas I., Talero E., de la Lastra C. A. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol: 2010; 633 78 84
7. Deguchi Y., Andoh A., Inatomi O., Yagi Y., Bamba S., Araki Y., Hata K., Tsujikawa T., Fujiyama Y. Curcumin prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis. Dig Dis Sci: 2007; 52 2993 2998 (Pubitemid 47512496)
8. Ye Z., Liu Z., Henderson A., Lee K., Hostetter J., Wannemuehler M., Hendrich S. Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice. Exp Biol Med (Maywood): 2009; 234 605 616
9. Kwon K. H., Murakami A., Tanaka T., Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice, attenuation of pro-inflammatory gene expression. Biochem Pharmacol: 2005; 69 395 406 (Pubitemid 40094500)
10. Andújar I., Recio M. C., Giner R. M., Cienfuegos-Jovellanos E., Laghi S., Muguerza B., Ríos J. L. Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by inhibition of STAT1 and STAT3 phosphorylation in colon cells. J Agric Food Chem: 2011; 59 6474 6483
11. Giner E., Andújar I., Recio M. C., Ríos J. L., Cerdá-Nicolás J. M., Giner R. M. Oleuropein ameliorates acute colitis in mice. J Agric Food Chem: 2011; 59 12882 12892
12. Andújar I., Ríos J. L., Giner R. M., Cerdá M. J., Recio M. C. Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in BALB/c mice. Evid Based Complement Alternat Med: 2012; 2012 271606
13. Kim S. J., Kim M. C., Um J. Y., Hong S. H. The beneficial effect of vanillic acid on ulcerative colitis. Molecules: 2010; 15 7208 7217
14. Peters E. A., Hiltermann J. T., Stolk J. Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics. Free Radic Biol Med: 2001; 31 1442 1447 (Pubitemid 33145314)
15. Pandey A., Kour K., Bani S., Suri K. A., Satti N. K., Sharma P., Qazi G. N. Amelioration of adjuvant induced arthritis by apocynin. Phytother Res: 2009; 23 1462 1468
16. Impellizzeri D., Esposito E., Mazzon E., Paterniti I., Di Paola R., Bramanti P., Cuzzocrea S. Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol: 2011; 81 636 648
17. Kim S. Y., Moon K. A., Jo H. Y., Jeong S., Seon S. H., Jung E., Cho Y. S., Chun E., Lee K. Y. Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation. Immunol Cell Biol: 2012; 90 441 448
18. Palmen M. JHJ, Beukelman C. J., Mooij R. GM, Meuwissen S. GM, van Rees E. P. Beneficial effect of apocynin, a plant-derived NADPH oxidase antagonist, in TNBS-induced experimental colitis. Immunol Microbiol Inflamm Disord: 1995; A889
19. Rachmilewitz D., Okon E., Karmeli F. Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohns disease. Gut: 1997; 41 358 365 (Pubitemid 27428196)
20. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J: 2008; 22 659 661 (Pubitemid 351348146)
21. Cooper H. S., Murthy S. N., Shah R. S., Sedergran D. J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest: 1993; 69 238 249
22. Sann H., Erichsen J. V., Hessmann M., Pahl A., Hoffmeyer A. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice. Life Sci: 2013; 92 708 718
23. Axelsson L. G., Landström E., Bylund-Fellenius A. C. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther: 1998; 12 925 934 (Pubitemid 28428959)
24. Kwon K. H., Murakami A., Tanaka T., Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol: 2005; 69 395 406 (Pubitemid 40094500)
25. Hur S. J., Kang S. H., Jung H. S., Kim S. C., Jeon H. S., Kim I. H., Lee J. D. Review of natural products actions on cytokines in inflammatory bowel disease. Nutr Res: 2012; 32 801 816
26. Soriano A., Salas A., Salas A., Sans M., Gironella M., Elena M., Anderson D. C., Piqué J. M., Panés J. VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice. Lab Invest: 2000; 80 1541 1551
27. Sans M., Panés J., Ardite E., Elizalde J. I., Arce Y., Elena M., Palacín A., Fernández-Checa J. C., Anderson D. C., Lobb R., Piqué J. M. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology: 1999; 116 874 883 (Pubitemid 29153535)
28. Rumi G., Tsubouchi R., Nishio H., Kato S., Mózsik G., Takeuchi K. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats. J Physiol Pharmacol: 2004; 55 823 836 (Pubitemid 40053048)
29. Arafa H. M., Hemeida R. A., El-Bahrawy A. I., Hamada F. M. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food Chem Toxicol: 2009; 47 1311 1317
30. Mäkelä S. M., Strengell M., Pietilä T. E., Osterlund P., Julkunen I. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leukoc Biol: 2009; 85 664 672
31. Domènech E. Inflammatory bowel disease, current therapeutic options. Digestion: 2006; 73 67 76
32. Jiang R., Wang H., Deng L., Hou J., Shi R., Yao M., Gao Y., Yao A., Wang X., Yu L., Sun B. IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer: 2013; 13 59
33. Li Y., de Haar C., Chen M., Deuring J., Gerrits M. M., Smits R., Xia B., Kuipers E. J., van der Woude C. J. Disease-related expression of the IL6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut: 2010; 59 227 235
34. Lee M. J., Lee J. K., Choi J. W., Lee C. S., Sim J. H., Cho C. H., Lee K. H., Cho I. H., Chung M. H., Kim H. R., Ye S. K. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS One: 2012; 7 e38801
35. Itoh A., Isoda K., Kondoh M., Kawase M., Kobasashi M., Tamesada M., Yagi K. Hepatoprotective effect of syringic acid and vanillic acid on concanavalin a-induced liver injury. Biol Pharm Bull: 2009; 32 1215 1219
36. Simons J. M., Hart B. A., Ip Vai Ching T. R., Van Dijk H., Labadie R. P. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med: 1990; 8 251 258
37. Wong A. P., Clark A. L., Garnett E. A., Acree M., Cohen S. A., Ferry G. D., Heyman M. B. Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey. J Pediatr Gastroenterol Nutr: 2009; 48 55 60
38. Suskind D. L., Wahbeh G., Burpee T., Cohen M., Christie D., Weber W. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. J Pediatr Gastroenterol Nutr: 2013; 56 277 279
39. Peters E. A., Hiltermann J. T., Stolk J. Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics. Free Radic Biol Med: 2001; 31 1442 1447 (Pubitemid 33145314)
40. Sugimoto K., Hanai H., Tozawa K., Aoshi T., Uchijima M., Nagata T., Koide Y. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology: 2002; 123 1912 1922 (Pubitemid 35408315)
41. Deguchi Y., Andoh A., Inatomi O., Yagi Y., Bamba S., Araki Y., Hata K., Tsujikawa T., Fujiyama Y. Curcumin prevents the development of dextran sulfate Sodium (DSS)-induced experimental colitis. Dig Dis Sci: 2007; 52 2993 2998 (Pubitemid 47512496)
42. Billerey-Larmonier C., Uno J. K., Larmonier N., Midura A. J., Timmermann B., Ghishan F. K., Kiela P. R. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis: 2008; 14 780 793 (Pubitemid 351898063)
43. Suzuki K., Ota H., Sasagawa S., Sakatani T., Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem: 1983; 132 345 352 (Pubitemid 13048589)
44. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem: 1976; 72 248 254